Date published: 2026-4-4

1-800-457-3801

SCBT Portrait Logo
Seach Input

RYK Activators

RYK, a receptor-like tyrosine kinase, is intricately involved in diverse cellular processes, and its activity can be modulated by various small molecules. The following chemicals serve as activators of RYK, either through direct interactions or by influencing interconnected signaling pathways: CCG-1423 and Y-27632: CCG-1423 and Y-27632 indirectly activate RYK by inhibiting Rho-associated protein kinase (ROCK). The inhibition of ROCK alters cytoskeletal dynamics and cellular morphology, indirectly modulating RYK activity through downstream signaling pathways. DAPT and IWP-2: DAPT and IWP-2 indirectly activate RYK by inhibiting the Notch and Wnt pathways, respectively. Inhibition of these pathways leads to changes in downstream signaling cascades, influencing RYK activity through crosstalk between these signaling networks. LDN-214117 and SU5402: LDN-214117 and SU5402 indirectly activate RYK by inhibiting BMP and FGFR signaling, respectively. Inhibition of these receptors alters the balance of signaling pathways, influencing RYK activity through modulation of downstream cascades.

SIS3 and SB431542: SIS3 and SB431542 indirectly activate RYK by inhibiting Smad3 and TGF-β type I receptor (ALK5), respectively. Inhibition of these components impacts TGF-β signaling, leading to changes in downstream pathways that influence RYK activity. XAV939 and Niclosamide: XAV939 and Niclosamide indirectly activate RYK by inhibiting tankyrase and the Wnt/β-catenin pathway, respectively. Inhibition of these components influences RYK activity through changes in downstream signaling networks. PF-431396 and XMD8-92: PF-431396 and XMD8-92 indirectly activate RYK by inhibiting FAK/PYK2 and Wee1 kinase, respectively. Inhibition of these components alters cellular adhesion, migration, and cell cycle progression, indirectly influencing RYK activity through downstream cascades. These diverse activators highlight the complexity of RYK regulation and its integration into multiple signaling networks. The interconnected nature of these pathways emphasizes the need for a comprehensive understanding of the crosstalk between RYK and other cellular processes.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

CCG-1423

285986-88-1sc-205241
sc-205241A
1 mg
5 mg
$30.00
$90.00
8
(1)

CCG-1423 is a small molecule inhibitor of Rho-associated protein kinase (ROCK), which indirectly activates RYK by inhibiting ROCK. The inhibition of ROCK influences cytoskeletal dynamics and cellular morphology, indirectly modulating RYK activity through alterations in downstream signaling pathways.

DAPT

208255-80-5sc-201315
sc-201315A
sc-201315B
sc-201315C
5 mg
25 mg
100 mg
1 g
$40.00
$120.00
$480.00
$2141.00
47
(3)

DAPT is a γ-secretase inhibitor that indirectly activates RYK by inhibiting the Notch signaling pathway. The inhibition of γ-secretase prevents the cleavage of Notch receptors, leading to changes in Notch signaling and subsequently influencing RYK activity through crosstalk between these pathways.

FLI-06

313967-18-9sc-497529
5 mg
$82.00
(0)

LDN-214117 is a small molecule inhibitor of BMP type I receptors, indirectly activating RYK by inhibiting BMP signaling. Inhibition of BMP receptors alters the balance of BMP signaling, influencing RYK activity through the modulation of downstream signaling cascades.

SIS3 hydrochloride

521984-48-5sc-253565
5 mg
$334.00
2
(1)

SIS3 is a selective inhibitor of Smad3, indirectly activating RYK by inhibiting the TGF-β/Smad signaling pathway. Inhibition of Smad3 impacts TGF-β signaling, leading to changes in downstream pathways that influence RYK activity.

SU 5402

215543-92-3sc-204308
sc-204308A
1 mg
5 mg
$63.00
$98.00
36
(3)

SU5402 is a fibroblast growth factor receptor (FGFR) inhibitor, indirectly activating RYK by inhibiting FGFR signaling. Inhibition of FGFR alters the balance of FGFR-dependent pathways, influencing RYK activity through cross-regulation between these signaling cascades.

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$36.00
$117.00
$525.00
26
(1)

XAV939 is a tankyrase inhibitor that indirectly activates RYK by stabilizing Axin1 and promoting β-catenin degradation. The inhibition of tankyrase influences the Wnt/β-catenin signaling pathway, leading to changes in β-catenin-dependent transcription and subsequently impacting RYK activity.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

SB431542 is an inhibitor of the transforming growth factor-beta (TGF-β) type I receptor, ALK5, indirectly activating RYK by inhibiting TGF-β signaling. Inhibition of ALK5 alters the balance of TGF-β signaling, leading to changes in downstream pathways that influence RYK activity.

Niclosamide

50-65-7sc-250564
sc-250564A
sc-250564B
sc-250564C
sc-250564D
sc-250564E
100 mg
1 g
10 g
100 g
1 kg
5 kg
$38.00
$79.00
$188.00
$520.00
$1248.00
$5930.00
8
(1)

Niclosamide is an anthelmintic drug that indirectly activates RYK by inhibiting the Wnt/β-catenin signaling pathway. The inhibition of Wnt/β-catenin signaling alters the dynamics of the pathway, influencing RYK activity through cross-talk between Wnt and RYK-dependent pathways.

IWP-2

686770-61-6sc-252928
sc-252928A
5 mg
25 mg
$96.00
$292.00
27
(1)

IWP-2 is a porcupine inhibitor that indirectly activates RYK by inhibiting Wnt secretion. Inhibition of porcupine impacts the secretion and availability of Wnt ligands, influencing RYK activity through modulation of the Wnt signaling pathway.

XMD 8-92 (free base)

1234480-50-2sc-364068
sc-364068A
sc-364068B
sc-364068C
5 mg
10 mg
100 mg
1 g
$235.00
$340.00
$1700.00
$10330.00
10
(0)

XMD8-92 is a small molecule inhibitor of Wee1 kinase, indirectly activating RYK by inhibiting the G2/M cell cycle checkpoint. Inhibition of Wee1 alters cell cycle progression, influencing RYK activity through changes in downstream signaling cascades.